4350 MEDICAL SYSTEM NETWORK Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4350

TSE Standard

MEDICAL SYSTEM NETWORK Co., Ltd.

418

JPY

(+1.46%)

Dec 23, 3:30 pm JST

2.66

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	104,257	3,429	3,479	2,198	72.5	10	May 7, 2021	J-GAAP
Mar, 2022	106,685	3,852	4,313	2,394	79.4	12	May 6, 2022	J-GAAP
Mar, 2023	109,551	3,163	3,355	1,610	53.4	12	May 9, 2023	J-GAAP
Mar, 2024	115,361	3,832	3,825	1,860	61.9	12	May 10, 2024	J-GAAP
Mar, 2025 Guidance	122,000	3,000	3,000	1,250	42.8	12	Oct 31, 2024	J-GAAP
YoY	+5.8%	-21.7%	-21.6%	-32.8%	-30.9%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 8, 2019	103,000	2,500	2,400	650	10	J-GAAP
	Mar 25, 2020	105,000	1,530	1,500	-250	10	J-GAAP
Results	May 8, 2020	105,241	1,615	1,560	-895	10	J-GAAP
Mar, 2021	May 8, 2020	Available in future release
	Nov 6, 2020
	Dec 15, 2020
	Feb 5, 2021
Results	May 7, 2021
Mar, 2022	May 7, 2021
	Feb 4, 2022
Results	May 6, 2022
Mar, 2023	May 6, 2022
Results	May 9, 2023
Mar, 2024	May 9, 2023
	Nov 7, 2023
Results	May 10, 2024
Mar, 2025	May 10, 2024	122,000	4,000	3,950	2,000	12	J-GAAP
	Oct 31, 2024	122,000	3,000	3,000	1,250	12	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Sep, 2000	216	－	Available in future release
Sep, 2001	430	+99.1
Sep, 2002	626	+45.6
Sep, 2003	11,397	+1,720.6
Sep, 2004	14,091	+23.6
Sep, 2005	17,558	+24.6
Sep, 2006	30,625	+74.4
Sep, 2007	32,066	+4.7
Sep, 2008	33,785	+5.4
Sep, 2009	36,786	+8.9
Sep, 2010	41,131	+11.8
Sep, 2011	46,508	+13.1
Mar, 2012 Changed	25,410	－
Mar, 2013	54,827	+115.8
Mar, 2014	66,181	+20.7
Mar, 2015	75,548	+14.2
Mar, 2016	87,715	+16.1
Mar, 2017	88,865	+1.3
Mar, 2018	93,977	+5.8
Mar, 2019	98,232	+4.5
Mar, 2020	105,241	+7.1
Mar, 2021	104,257	-0.9
Mar, 2022	106,685	+2.3
Mar, 2023	109,551	+2.7
Mar, 2024	115,361	+5.3
Mar, 2025 Guidance	122,000	+5.8	3,000	-21.7	3,000	-21.6	42.8	-30.9

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	109,551	3,163	2.89	11.62	2.49	1.70	53.4
Mar, 2024	115,361	3,832	3.32	12.56	2.77	1.72	61.9
Mar, 2025 Guidance	122,000	3,000	2.46	8.22	1.79	1.74	42.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	115,361	3,852	4,313	2,394	79.4
Fiscal Year	Mar, 2024	Mar, 2022	Mar, 2022	Mar, 2022	Mar, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	54,516	1,990	2,078	963	31.9	7	May 6, 2022	J-GAAP
Oct - Mar, 2022	56,211	2,064	2,113	1,108	36.7	6	May 9, 2023	J-GAAP
Oct - Mar, 2023	58,900	2,120	2,133	999	33.2	6	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	62,239	1,973	1,980	1,043	35.7	6	Oct 31, 2024	J-GAAP
YoY	+5.7%	-6.9%	-7.2%	+4.4%	+7.4%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	3,852	1,499	4,010	-2,511	-3,415	8,171	12.98	J-GAAP
Mar, 2023	3,163	2,859	4,973	-2,114	-2,918	8,111	12.25	J-GAAP
Mar, 2024	3,832	4,076	7,725	-3,649	-3,944	8,242	12.09	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	53,340	1,099	1,242	502	16.6	37.0	Nov 4, 2022	J-GAAP
Apr - Sep, 2023	56,461	1,712	1,692	861	28.5	44.2	Nov 7, 2023	J-GAAP
Apr - Sep, 2024	59,761	1,027	1,020	207	7.1	34.0	Nov 8, 2024	J-GAAP
YoY	+5.8%	-40.0%	-39.7%	-76.0%	-75.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	28,538	1,245	1,257	693	23.0	4.4	Feb 3, 2023	J-GAAP
Jan - Mar, 2023	27,673	819	856	415	13.8	3.0	May 9, 2023	J-GAAP
Apr - Jun, 2023	27,656	451	410	148	4.9	1.6	Aug 8, 2023	J-GAAP
Jul - Sep, 2023	28,805	1,261	1,282	713	23.6	4.4	Nov 7, 2023	J-GAAP
Oct - Dec, 2023	29,714	1,357	1,352	832	27.6	4.6	Feb 6, 2024	J-GAAP
Jan - Mar, 2024	29,186	763	781	167	5.6	2.6	May 10, 2024	J-GAAP
Apr - Jun, 2024	29,419	468	468	170	5.9	1.6	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	30,342	559	552	37	1.3	1.8	Nov 8, 2024	J-GAAP
YoY	+5.3%	-55.7%	-56.9%	-94.8%	-94.6%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	26,727	+6.1	Available in future release
Jan - Mar, 2020	26,298	+3.2
Apr - Jun, 2020	25,162	-1.7
Jul - Sep, 2020	25,883	-2.8
Oct - Dec, 2020	27,122	+1.5
Jan - Mar, 2021	26,090	-0.8
Apr - Jun, 2021	25,914	+3.0
Jul - Sep, 2021	26,255	+1.4
Oct - Dec, 2021	27,699	+2.1
Jan - Mar, 2022	26,817	+2.8
Apr - Jun, 2022	26,299	+1.5
Jul - Sep, 2022	27,041	+3.0
Oct - Dec, 2022	28,538	+3.0
Jan - Mar, 2023	27,673	+3.2
Apr - Jun, 2023	27,656	+5.2
Jul - Sep, 2023	28,805	+6.5
Oct - Dec, 2023	29,714	+4.1
Jan - Mar, 2024	29,186	+5.5
Apr - Jun, 2024	29,419	+6.4
Jul - Sep, 2024	30,342	+5.3	559	-55.7	552	-56.9	1.3	-94.5

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	30,342	1,418	1,459	1,435	47.3
Fiscal Year	Sep, 2024	Dec, 2020	Sep, 2020	Dec, 2020	Dec, 2020

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	439.67	21.1	62,941	13,268	10,393	2.23	May 6, 2022	J-GAAP
Mar, 2023	478.86	21.8	66,223	14,451	11,606	2.11	May 9, 2023	J-GAAP
Mar, 2024	519.06	22.3	68,149	15,171	13,100	1.58	May 10, 2024	J-GAAP
Apr - Sep, 2024	520.26	21.7	69,976	15,206	13,124	1.65	Nov 8, 2024	J-GAAP

MEDICAL SYSTEM NETWORK Co., Ltd.(4350) Financial Results